It's sort of the, the manual of Psychiatric disorders. And I think that we're on the DSM 5, as it's called, which is the fifth edition of this manual. You have Drug companies are lobbying to have child dysphoria put into our psychiatric manuals. Because then psychiatrists will treat that condition and then those pharmaceutical companies will get rich from it. Somebody should be interrogating whether the political incentives of our country actually align with the financial incentives of the pharmaceutical industry. (28:20–28:31)
CLAIM
Asserts that pharmaceutical companies are influencing psychiatric classifications for profit.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
